Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Prostatectomy & nephrectomy · District of Columbia | Prostatectomy & nephrectomy · Texas | |
|---|---|---|
| Surgeons, 2024 | 8 | 41 |
| Medicare fee-for-service cases | 277 | 2,635 |
| Growth since 2019 (Medicare FFS) | +5.5%/yr | −0.3%/yr |
| Forecast cases (Medicare FFS) | 380 in 2030 | 3,600 in 2030 |
| Forecast growth | +5.5%/yr to 2030 | +5.4%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 4.7 | 1.3 |
| Medicare Advantage share | 39% | 59% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 35 | 64 |
| Top 10 surgeons' share | 100% | 49% |
| Surgeons growing | 0 | 2 |
| New since the base year | 2 | 1 |
| Likely to stop billing it | 1 by 2026 | 12 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $5,765 | $16K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.